# DHI Group, Inc.: financial statements, quarterly DHX · NYSE · CIK 1393883 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dhx.md) · [Financials](/companies/dhx/financials.md) · [Filings](/companies/dhx/filings.md) · [Insiders](/companies/dhx/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dhx/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [37.4](/filings/0001393883-24-000113.md) | [37.3 d](/filings/0001393883-26-000041.md) | [36.0](/filings/0001393883-25-000080.md) | [35.8](/filings/0001393883-25-000106.md) | [35.3](/filings/0001393883-25-000120.md) | [34.8 d](/filings/0001393883-26-000041.md) | [32.3](/filings/0001393883-26-000070.md) | [32.0](/filings/0001393883-26-000108.md) | [32.1](/filings/0001393883-25-000120.md) | [31.4 d](/filings/0001393883-26-000041.md) | [29.7](/filings/0001393883-26-000070.md) | [31.3](/filings/0001393883-26-000108.md) | | Cost of revenue | $m | [5.0](/filings/0001393883-24-000113.md) | [4.9 d](/filings/0001393883-26-000041.md) | [4.9](/filings/0001393883-25-000080.md) | [5.2](/filings/0001393883-25-000106.md) | [5.1](/filings/0001393883-25-000120.md) | [5.1 d](/filings/0001393883-26-000041.md) | [5.4](/filings/0001393883-26-000070.md) | [5.1](/filings/0001393883-26-000108.md) | [4.6](/filings/0001393883-25-000120.md) | [4.5 d](/filings/0001393883-26-000041.md) | [4.8](/filings/0001393883-26-000070.md) | [6.3](/filings/0001393883-26-000108.md) | | Research and development | $m | [4.4](/filings/0001393883-24-000113.md) | [4.5 d](/filings/0001393883-26-000041.md) | [4.8](/filings/0001393883-25-000080.md) | [4.7](/filings/0001393883-25-000106.md) | [4.8](/filings/0001393883-25-000120.md) | [4.6 d](/filings/0001393883-26-000041.md) | [3.8](/filings/0001393883-26-000070.md) | [3.1](/filings/0001393883-26-000108.md) | [2.9](/filings/0001393883-25-000120.md) | [3.0 d](/filings/0001393883-26-000041.md) | [3.1](/filings/0001393883-26-000070.md) | [2.9](/filings/0001393883-26-000108.md) | | Operating income | $m | [2.2](/filings/0001393883-24-000113.md) | [3.5 d](/filings/0001393883-26-000041.md) | [2.0](/filings/0001393883-25-000080.md) | [2.0](/filings/0001393883-25-000106.md) | [0.6](/filings/0001393883-25-000120.md) | [1.7 d](/filings/0001393883-26-000041.md) | [(9.3)](/filings/0001393883-26-000070.md) | [(1.3)](/filings/0001393883-26-000108.md) | [(4.5)](/filings/0001393883-25-000120.md) | [3.7 d](/filings/0001393883-26-000041.md) | [3.1](/filings/0001393883-26-000070.md) | [3.8](/filings/0001393883-26-000108.md) | | Interest expense | $m | [0.9](/filings/0001393883-24-000113.md) | [0.9 d](/filings/0001393883-26-000041.md) | [0.9](/filings/0001393883-25-000080.md) | [0.8](/filings/0001393883-25-000106.md) | [0.8](/filings/0001393883-25-000120.md) | [0.7 d](/filings/0001393883-26-000041.md) | [0.7](/filings/0001393883-26-000070.md) | [0.6](/filings/0001393883-26-000108.md) | [0.6](/filings/0001393883-25-000120.md) | [0.6 d](/filings/0001393883-26-000041.md) | [0.6](/filings/0001393883-26-000070.md) | [0.7](/filings/0001393883-26-000108.md) | | Income tax | $m | [0.8](/filings/0001393883-24-000113.md) | [0.6 d](/filings/0001393883-26-000041.md) | [2.3](/filings/0001393883-25-000080.md) | [0.4](/filings/0001393883-25-000106.md) | [0.1](/filings/0001393883-25-000120.md) | [(0.1) d](/filings/0001393883-26-000041.md) | [(0.1)](/filings/0001393883-26-000070.md) | [(1.1)](/filings/0001393883-26-000108.md) | [(0.8)](/filings/0001393883-25-000120.md) | [0.8 d](/filings/0001393883-26-000041.md) | [1.0](/filings/0001393883-26-000070.md) | [0.5](/filings/0001393883-26-000108.md) | | Net income | $m | [1.0](/filings/0001393883-24-000113.md) | [2.1 d](/filings/0001393883-26-000041.md) | [(1.5)](/filings/0001393883-25-000080.md) | [0.9](/filings/0001393883-25-000106.md) | [(0.2)](/filings/0001393883-25-000120.md) | [1.0 d](/filings/0001393883-26-000041.md) | [(9.8)](/filings/0001393883-26-000070.md) | [(0.8)](/filings/0001393883-26-000108.md) | [(4.3)](/filings/0001393883-25-000120.md) | [1.4 d](/filings/0001393883-26-000041.md) | [1.5](/filings/0001393883-26-000070.md) | [2.6](/filings/0001393883-26-000108.md) | | Diluted EPS | $ per share | [0.02](/filings/0001393883-24-000113.md) | not reported | [(0.03)](/filings/0001393883-25-000080.md) | [0.02](/filings/0001393883-25-000106.md) | [0.00](/filings/0001393883-25-000120.md) | not reported | [(0.21)](/filings/0001393883-26-000070.md) | [(0.02)](/filings/0001393883-26-000108.md) | [(0.10)](/filings/0001393883-25-000120.md) | not reported | [0.04](/filings/0001393883-26-000070.md) | [0.06](/filings/0001393883-26-000108.md) | | Basic EPS | $ per share | [0.02](/filings/0001393883-24-000113.md) | not reported | [(0.03)](/filings/0001393883-25-000080.md) | [0.02](/filings/0001393883-25-000106.md) | [0.00](/filings/0001393883-25-000120.md) | not reported | [(0.21)](/filings/0001393883-26-000070.md) | [(0.02)](/filings/0001393883-26-000108.md) | [(0.10)](/filings/0001393883-25-000120.md) | not reported | [0.04](/filings/0001393883-26-000070.md) | [0.06](/filings/0001393883-26-000108.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [3.7](/filings/0001393883-23-000154.md) | [4.2](/filings/0001393883-25-000041.md) | [3.2](/filings/0001393883-24-000088.md) | [3.0](/filings/0001393883-24-000102.md) | [2.1](/filings/0001393883-24-000113.md) | [3.7](/filings/0001393883-26-000041.md) | [2.7](/filings/0001393883-25-000080.md) | [2.8](/filings/0001393883-25-000106.md) | [2.3](/filings/0001393883-25-000120.md) | [2.9](/filings/0001393883-26-000108.md) | [3.0](/filings/0001393883-26-000070.md) | [3.8](/filings/0001393883-26-000108.md) | | Current assets | $m | [27.1](/filings/0001393883-23-000154.md) | [30.9](/filings/0001393883-25-000041.md) | [38.0](/filings/0001393883-24-000088.md) | [29.3](/filings/0001393883-24-000102.md) | [26.0](/filings/0001393883-24-000113.md) | [29.7](/filings/0001393883-26-000041.md) | [30.0](/filings/0001393883-25-000080.md) | [25.8](/filings/0001393883-25-000106.md) | [23.9](/filings/0001393883-25-000120.md) | [24.5](/filings/0001393883-26-000108.md) | [25.4](/filings/0001393883-26-000070.md) | [23.4](/filings/0001393883-26-000108.md) | | Total assets | $m | [220](/filings/0001393883-23-000154.md) | [225](/filings/0001393883-25-000041.md) | [232](/filings/0001393883-24-000088.md) | [224](/filings/0001393883-24-000102.md) | [219](/filings/0001393883-24-000113.md) | [221](/filings/0001393883-26-000041.md) | [212](/filings/0001393883-25-000080.md) | [205](/filings/0001393883-25-000106.md) | [192](/filings/0001393883-25-000120.md) | [188](/filings/0001393883-26-000108.md) | [192](/filings/0001393883-26-000070.md) | [189](/filings/0001393883-26-000108.md) | | Current liabilities | $m | [65.1](/filings/0001393883-23-000154.md) | [68.9](/filings/0001393883-25-000041.md) | [72.9](/filings/0001393883-24-000088.md) | [65.6](/filings/0001393883-24-000102.md) | [62.6](/filings/0001393883-24-000113.md) | [62.7](/filings/0001393883-26-000041.md) | [63.5](/filings/0001393883-25-000080.md) | [61.8](/filings/0001393883-25-000106.md) | [55.9](/filings/0001393883-25-000120.md) | [55.1](/filings/0001393883-26-000108.md) | [57.2](/filings/0001393883-26-000070.md) | [53.1](/filings/0001393883-26-000108.md) | | Total liabilities | $m | [117](/filings/0001393883-23-000154.md) | [118](/filings/0001393883-25-000041.md) | [125](/filings/0001393883-24-000088.md) | [115](/filings/0001393883-24-000102.md) | [108](/filings/0001393883-24-000113.md) | [107](/filings/0001393883-26-000041.md) | [108](/filings/0001393883-25-000080.md) | [102](/filings/0001393883-25-000106.md) | [95.2](/filings/0001393883-25-000120.md) | [93.7](/filings/0001393883-26-000108.md) | [99.5](/filings/0001393883-26-000070.md) | [94.6](/filings/0001393883-26-000108.md) | | Long-term debt | $m | [40.0](/filings/0001393883-23-000154.md) | [38.0](/filings/0001393883-25-000041.md) | [41.0](/filings/0001393883-24-000088.md) | [35.0](/filings/0001393883-24-000102.md) | [32.0](/filings/0001393883-24-000113.md) | [32.0](/filings/0001393883-26-000041.md) | [33.0](/filings/0001393883-25-000080.md) | [30.0](/filings/0001393883-25-000106.md) | [30.0](/filings/0001393883-25-000120.md) | [30.0](/filings/0001393883-26-000108.md) | [33.0](/filings/0001393883-26-000070.md) | [32.0](/filings/0001393883-26-000108.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [103](/filings/0001393883-23-000154.md) | [108](/filings/0001393883-26-000041.md) | [107](/filings/0001393883-24-000088.md) | [110](/filings/0001393883-24-000102.md) | [111](/filings/0001393883-24-000113.md) | [114](/filings/0001393883-26-000041.md) | [104](/filings/0001393883-25-000080.md) | [102](/filings/0001393883-25-000106.md) | [97.3](/filings/0001393883-25-000120.md) | [94.5](/filings/0001393883-26-000108.md) | [92.5](/filings/0001393883-26-000070.md) | [94.1](/filings/0001393883-26-000108.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [5,647 d](/filings/0001393883-24-000113.md) | [7,621 d](/filings/0001393883-26-000041.md) | [2,087](/filings/0001393883-25-000080.md) | [9,063 d](/filings/0001393883-25-000106.md) | [5,526 d](/filings/0001393883-25-000120.md) | [4,369 d](/filings/0001393883-26-000041.md) | [2,248](/filings/0001393883-26-000070.md) | [6,866 d](/filings/0001393883-26-000108.md) | [4,763 d](/filings/0001393883-25-000120.md) | [7,225 d](/filings/0001393883-26-000041.md) | [8,411](/filings/0001393883-26-000070.md) | [6,098 d](/filings/0001393883-26-000108.md) | | Capital expenditure | $k | [5,767 d](/filings/0001393883-24-000113.md) | [5,264 d](/filings/0001393883-26-000041.md) | [4,442](/filings/0001393883-25-000080.md) | [3,471 d](/filings/0001393883-25-000106.md) | [3,233 d](/filings/0001393883-25-000120.md) | [2,786 d](/filings/0001393883-26-000041.md) | [2,160](/filings/0001393883-26-000070.md) | [2,025 d](/filings/0001393883-26-000108.md) | [1,593 d](/filings/0001393883-25-000120.md) | [1,531 d](/filings/0001393883-26-000041.md) | [1,648](/filings/0001393883-26-000070.md) | [1,610 d](/filings/0001393883-26-000108.md) | | Share repurchases | $k | [0.0 d](/filings/0001393883-24-000113.md) | [0.0 d](/filings/0001393883-26-000041.md) | [0.0](/filings/0001393883-25-000080.md) | [0.0 d](/filings/0001393883-25-000106.md) | [0.0 d](/filings/0001393883-25-000120.md) | [0.0 d](/filings/0001393883-26-000041.md) | [666](/filings/0001393883-26-000070.md) | [1,769 d](/filings/0001393883-26-000108.md) | [2,082 d](/filings/0001393883-25-000120.md) | [5,138 d](/filings/0001393883-26-000041.md) | [3,812](/filings/0001393883-26-000070.md) | [1,926 d](/filings/0001393883-26-000108.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [44.2](/filings/0001393883-23-000154.md) | [45.2](/filings/0001393883-24-000088.md) | [43.5](/filings/0001393883-24-000102.md) | [44.3](/filings/0001393883-24-000113.md) | [44.2](/filings/0001393883-25-000080.md) | [45.0](/filings/0001393883-25-000106.md) | [44.9](/filings/0001393883-25-000120.md) | [45.5](/filings/0001393883-26-000070.md) | [45.4](/filings/0001393883-26-000108.md) | [44.8](/filings/0001393883-25-000120.md) | [42.4](/filings/0001393883-26-000070.md) | [42.1](/filings/0001393883-26-000108.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 43,424,190 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001393883-26-000108.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.